ストックスクリーナーアプリを入手
68.93
1.50%
-1.05
アフターアワーズ：
68.93
前日終値:
$69.98
開ける：
$68.44
24時間の取引高:
612.97K
Relative Volume:
0.57
時価総額：
$3.21B
収益：
-
当期純損益:
$-38.99M
株価収益率:
-23.00
EPS:
-2.9966
ネットキャッシュフロー:
$-24.94M
1週間 パフォーマンス:
-1.53%
1か月 パフォーマンス:
+40.36%
6か月 パフォーマンス:
+28.24%
1年 パフォーマンス:
+83.81%
1日の値動き範囲:
$68.30
$71.15
1週間の範囲:
$68.27
$71.15
52週間の値動き範囲:
$36.93
$74.00
Soleno Therapeutics Inc Stock (SLNO) Company Profile
名前
Soleno Therapeutics Inc
セクター
電話
650-213-8444
住所
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
SLNO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
68.93 | 3.21B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-05 | 再開されました | Stifel | Buy |
| 2024-12-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2024-12-02 | 繰り返されました | Stifel | Buy |
| 2024-09-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-10 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-05 | 開始されました | Piper Sandler | Overweight |
| 2024-01-23 | 開始されました | Stifel | Buy |
| 2023-11-21 | 再開されました | Guggenheim | Buy |
| 2020-09-29 | 開始されました | Guggenheim | Buy |
| 2020-01-10 | 開始されました | Craig Hallum | Buy |
| 2019-12-23 | 開始されました | Oppenheimer | Outperform |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Soleno Therapeutics Inc (SLNO) 最新ニュース
How To Trade (SLNO) - news.stocktradersdaily.com
Soleno Therapeutics appoints CBIZ CPAs as new auditor By Investing.com - Investing.com Nigeria
Soleno Therapeutics appoints CBIZ CPAs as new auditor - Investing.com Australia
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno launches Vykat XR (SLNO:NASDAQ) - Seeking Alpha
Soleno Therapeutics launches FDA-approved PWS treatment By Investing.com - Investing.com South Africa
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN
Soleno Therapeutics launches FDA-approved PWS treatment - Investing.com
Soleno Therapeutics Announces VYKAT(TM) XR Launch - GlobeNewswire
Breakthrough PWS Treatment VYKAT XR Now Available: First-Ever FDA Approval for Rare Disease - Stock Titan
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN
KLP Kapitalforvaltning AS Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno Therapeutics (SLNO) Gains FDA Approval for Prader-Willi T - GuruFocus
SLNO Quantitative Stock Analysis - Nasdaq
Capnia Inc stock soars to 52-week high, hits $74 mark - Investing.com
Soleno therapeutics SVP sells $265,156 in stock By Investing.com - Investing.com Australia
Soleno therapeutics SVP sells $265,156 in stock - Investing.com
Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 699,095 Shares - MarketBeat
Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod By Investing.com - Investing.com South Africa
Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod - Investing.com
High Growth Tech Stocks To Watch In The US April 2025 - simplywall.st
Soleno Therapeutics CEO sells $35.3 million in stock By Investing.com - Investing.com India
Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com Australia
Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com Australia
Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock By Investing.com - Investing.com Nigeria
Soleno Therapeutics exec sells shares worth $9.5 million By Investing.com - Investing.com South Africa
Soleno therapeutics director Matthew Pauls sells $424,797 in stock By Investing.com - Investing.com Canada
Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock - Investing.com India
Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com Australia
Soleno Therapeutics exec sells $700,330 in stock - Investing.com India
Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com Australia
Soleno Therapeutics Executives and Director Sell Shares - TradingView
Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com
Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock By Investing.com - Investing.com UK
Soleno Therapeutics CCO sells shares worth $2.48m By Investing.com - Investing.com UK
Soleno Therapeutics CFO sells $4.88 million in stock By Investing.com - Investing.com UK
Soleno Therapeutics Executives Sell Shares - TradingView
Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com
Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com Australia
Soleno stock price target raised to $100 at H.C. Wainwright By Investing.com - Investing.com South Africa
Soleno stock price target raised to $100 at H.C. Wainwright - Investing.com
Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock By Investing.com - Investing.com South Africa
Soleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS Treatment - Markets Insider
Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week? - Insider Monkey
10 Stocks Outperform Broader Market Last Week - Insider Monkey
Soleno Therapeutics Inc (SLNO) 財務データ
収益
当期純利益
現金流量
EPS
0.15%
4.32%
大文字化:
|
ボリューム (24 時間):